NCT04477837View on ClinicalTrials.gov

Prospective Comparison of Incidence of Heavy Menstrual Bleeding in Women Treated With Direct Oral Anticoagulants

CompletedOBSERVATIONAL
Enrollment

84

Participants

Timeline

Start Date

October 15, 2020

Primary Completion Date

May 31, 2024

Study Completion Date

June 15, 2024

Conditions
Heavy Menstrual Bleeding
Interventions
DRUG

Apixaban 5 MG

frequency of heavy menstrual bleeding

DRUG

Rivaroxaban 20 MG

frequency of heavy menstrual bleeding

DRUG

Edoxaban 60 MG

frequency of heavy menstrual bleeding

DRUG

Dabigatran 150 Mg Oral Capsule

frequency of heavy menstrual bleeding

Trial Locations (1)

60389

Cardioangiology Center Bethanien (CCB), Frankfurt am Main

All Listed Sponsors
lead

Cardioangiologisches Centrum Bethanien

OTHER

NCT04477837 - Prospective Comparison of Incidence of Heavy Menstrual Bleeding in Women Treated With Direct Oral Anticoagulants | Biotech Hunter | Biotech Hunter